<a href="https://laohu8.com/S/KALA">Kala Bio</a> Secures $375,000 Convertible Loan from Private Investor
Kala Bio Inc. has entered into a new Convertible Loan Agreement with an individual investor, under which the company will receive up to $375,000 in funding. The agreement stipulates that $187,500 will be provided by November 10, 2025, with the remaining $187,500 due by November 12, 2025, unless extended by mutual agreement. The proceeds are restricted to facilitating negotiations and finalizing an additional investment transaction with the lender, as well as preparing and filing the company's upcoming Quarterly Report. During this period, Kala Bio has agreed not to seek alternative investment offers. The loan may be converted into shares of common stock, and the securities issued under this agreement will be exempt from SEC registration under Regulation S, as the lender is a non-U.S. person. The company cautioned that failure to secure further financing could lead to the resumption of foreclosure efforts by Oxford on its assets.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-108844), on November 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.